Skip to main content
HR 3692 115th Congress House Crime and Law Enforcement Drug therapy Drug trafficking and controlled substances Drug, alcohol, tobacco use Health personnel Prescription drugs

Addiction Treatment Access Improvement Act of 2017

Introduced: September 7, 2017 Introduced by: Tonko, Paul Democratic · New York See on congress.gov
 Everywhere this bill has been 5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 25, 2018
Subcommittee Consideration and Mark-up Session Held.
Sep 21, 2017
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Sep 8, 2017
Referred to the Subcommittee on Health.
Sep 7, 2017
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sep 7, 2017
Introduced in House
 Plain-English summary Congressional Research Service

Addiction Treatment Access Improvement Act of 2017

This bill amends the Controlled Substances Act to revise the qualifications required for a practitioner to administer, dispense, or prescribe narcotic drugs for maintenance or detoxification treatment in an office-based opioid treatment program.

It increases the maximum patient limit for a qualifying practitioner who meets certain requirements. The maximum patient limit is the maximum number of patients a qualifying practitioner can treat at one time.

The bill expands qualifying practitioners to include additional nonphysician practitioners: clinical nurse specialists, certified registered nurse anesthetists, and certified nurse midwives.

It makes permanent the authorization for certain nonphysician practitioners to become qualifying practitioners.

What's happening now April 25, 2018

Subcommittee Consideration and Mark-up Session Held.

 Committees of jurisdiction 4